Your browser doesn't support javascript.
loading
Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer.
Price, T J; Bruhn, M A; Lee, C K; Hardingham, J E; Townsend, A R; Mann, K P; Simes, J; Weickhardt, A; Wrin, J W; Wilson, K; Gebski, V; Van Hazel, G; Robinson, B; Cunningham, D; Tebbutt, N C.
Afiliación
  • Price TJ; 1] Haematology-Oncology Department, The Queen Elizabeth Hospital, Woodville, SA 5011, Australia [2] School of Medicine, University of Adelaide, Adelaide, SA 5005, Australia.
  • Bruhn MA; School of Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
  • Lee CK; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW 2050, Australia.
  • Hardingham JE; 1] Haematology-Oncology Department, The Queen Elizabeth Hospital, Woodville, SA 5011, Australia [2] School of Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
  • Townsend AR; 1] Haematology-Oncology Department, The Queen Elizabeth Hospital, Woodville, SA 5011, Australia [2] School of Medicine, University of Adelaide, Adelaide, SA 5005, Australia.
  • Mann KP; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW 2050, Australia.
  • Simes J; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW 2050, Australia.
  • Weickhardt A; 1] Austin Health, Heidelberg, VIC 3084, Australia [2] Ludwig Institute for Cancer Research, Heidelberg, VIC 3084, Australia.
  • Wrin JW; Haematology-Oncology Department, The Queen Elizabeth Hospital, Woodville, SA 5011, Australia.
  • Wilson K; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW 2050, Australia.
  • Gebski V; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW 2050, Australia.
  • Van Hazel G; Sir Charles Gardiner Hospital, Perth, WA, Australia.
  • Robinson B; Christchurch Hospital, Christchurch, New Zealand.
  • Cunningham D; Royal Marsden Hospital, London, UK.
  • Tebbutt NC; 1] Austin Health, Heidelberg, VIC 3084, Australia [2] Ludwig Institute for Cancer Research, Heidelberg, VIC 3084, Australia.
Br J Cancer ; 112(6): 963-70, 2015 Mar 17.
Article en En | MEDLINE | ID: mdl-25742472
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Genes ras / Fosfatidilinositol 3-Quinasas / Mutación Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Br J Cancer Año: 2015 Tipo del documento: Article País de afiliación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Genes ras / Fosfatidilinositol 3-Quinasas / Mutación Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Br J Cancer Año: 2015 Tipo del documento: Article País de afiliación: Australia